SenesTech, Inc. (SNES)

In July 2025, SenesTech closed a warrant exercise, generating $4.4 million in gross proceeds, followed by another warrant exercise for $6.3 million in gross proceeds in August 2025. In August 2025, the company announced record revenue of $625,000 for the second quarter of 2025, a 36% year-over-year increase, with Evolve™ products contributing 83% of total revenue and achieving a record gross profit margin of 65.4%. The company also reported a strong cash position of $11.2 million as of August 5, 2025. In November 2025, SenesTech reported record third-quarter 2025 financial results, with revenues increasing by 43% to $690,000 compared to Q3 2024. Evolve® product sales grew 77% year-over-year, representing 85% of total revenue, and the adjusted EBITDA loss improved to a record $1.2 million. The company's cash and short-term investments stood at $10.2 million. Evolve™ Rat Birth Control became available online at HomeDepot.com in September 2025 and Lowes.com in November 2025. SenesTech also participated in investor conferences, including the Lytham Partners 2025 Consumer & Technology Investor Summit in August 2025 and the Lytham Partners Fall 2025 Investor Conference in September 2025. Despite these positive developments, the stock experienced a decline of 25.56% between December 26, 2024, and December 24, 2025, and over the past year, SNES stock has shown a -35.47% decrease.

There is an indication of seasonality in the demand for SenesTech's products. Rodent activity tends to become more noticeable with the advent of cooler weather in the Northern Hemisphere, as rodents seek warm refuge. This increased activity during cooler months suggests a potential rise in demand for pest control solutions, including SenesTech's fertility control products, during these periods.

SenesTech, Inc. is an agricultural biotechnology life-sciences company specializing in fertility management for pest control, operating within the Materials sector, specifically in the Specialty Chemicals and Biotechnology industries. The company's core mission is to provide effective, humane, and environmentally responsible pest management alternatives. Its major products include ContraPest®, a liquid bait that is the only U.S. EPA-registered contraceptive for male and female rats, and Evolve®, a soft bait that is an EPA-designated minimum-risk contraceptive. These products work by interfering with the reproductive systems of rodents to reduce populations without lethal methods.

Headquartered in Phoenix, Arizona, United States, SenesTech, Inc. serves both domestic and international markets. Recent expansions in its international reach include the addition of the Belize Raptor Center as an official distributor of Evolve® Rat Birth Control in November 2025. The company is also paving the way for product use in Australia and New Zealand. Within the U.S., SenesTech's products are utilized by pest management professionals in various settings, including commercial buildings, municipal spaces, agribusinesses, and sensitive locations like zoos. Evolve deployments have also expanded to additional neighborhoods in Chicago.

SenesTech, Inc. maintains a positive brand reputation, built on its commitment to humane, effective, and sustainable pest management. The company is recognized for its innovative, non-toxic, and environmentally responsible solutions. A significant factor in its reputation is ContraPest's status as the only U.S. EPA-registered contraceptive for male and female rats, and Evolve's designation as an EPA minimum-risk contraceptive. These products are highlighted for their humane design, non-bioaccumulative nature, and proven efficacy in reducing rat populations without adverse health effects on the rats themselves or other species. The company's focus on fertility control as an alternative to toxic poisons resonates with increasing consumer demand for sustainable practices.

SenesTech, Inc. is owned by a mix of institutional shareholders (8.89%), SenesTech insiders (67.17%), and retail investors (23.94%). Major institutional owners include Renaissance Technologies Llc, Sabby Management, Llc, Vanguard Group Inc, Corsair Capital Management, L.p., Geode Capital Management, Llc, DRW Securities, LLC, Millennium Management Llc, Essex Investment Management Co Llc, Morgan Stanley, State Street Corp, Vanguard Fiduciary Trust Co, Pfs Cap Mgt Co, Osaic Wealth, Inc., Citigroup Inc., and SBI Holdings, Inc. Key individual insider shareholders include Grover T. Wickersham (owning 23.74% of the company), Kenneth S. Siegel, Loretta Powers Mayer, Cheryl Ann Dyer, Robert E. Ramsey Jr., Kim Patrice Wolin, and Marc Dumont.